BIOMAT Database Logo BIOMAT Database Logo

Changes in HIV-1 viral load trends with highly active antiretroviral therapy. 2001

C B Chew, and M J Leroi, and C Workman, and D E Dwyer

UI MeSH Term Description Entries
D009517 New South Wales A state in southeastern Australia. Its capital is Sydney. It was discovered by Captain Cook in 1770 and first settled at Botany Bay by marines and convicts in 1788. It was named by Captain Cook who thought its coastline resembled that of South Wales. (From Webster's New Geographical Dictionary, 1988, p840 & Room, Brewer's Dictionary of Names, 1992, p377)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
January 1999, AIDS (London, England),
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
August 2004, Antiviral research,
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients.
March 2005, AIDS (London, England),
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy.
November 2001, Journal of acquired immune deficiency syndromes (1999),
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.
January 2011, HIV clinical trials,
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Undetectable HIV-1 viral load in the fluid of bullous skin lesion in a patient receiving highly active antiretroviral therapy.
May 2008, International journal of STD & AIDS,
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.
June 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy.
August 1999, European journal of haematology,
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.
July 2006, Journal of acquired immune deficiency syndromes (1999),
C B Chew, and M J Leroi, and C Workman, and D E Dwyer
Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
March 2001, AIDS research and human retroviruses,
Copied contents to your clipboard!